Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ACP CVE:FRE NYSE:MED On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACPAbrdn Income Credit Strategies Fund$5.71+0.6%$5.83$4.92▼$6.59N/AN/A639,535 shs516,405 shsFREFremont GoldC$0.15C$0.15C$0.05▼C$0.17C$8.71M0.4340,741 shs28,000 shsMEDMEDIFAST$12.45-1.5%$13.74$11.57▼$21.98$136.86M0.85210,690 shs300,208 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACPAbrdn Income Credit Strategies Fund+1.07%+1.61%-4.15%-3.57%-14.43%FREFremont Gold0.00%0.00%0.00%0.00%+15.38%MEDMEDIFAST-1.87%-3.96%-11.69%-16.66%-27.20%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACPAbrdn Income Credit Strategies Fund$5.71+0.6%$5.83$4.92▼$6.59N/AN/A639,535 shs516,405 shsFREFremont GoldC$0.15C$0.15C$0.05▼C$0.17C$8.71M0.4340,741 shs28,000 shsMEDMEDIFAST$12.45-1.5%$13.74$11.57▼$21.98$136.86M0.85210,690 shs300,208 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACPAbrdn Income Credit Strategies Fund+1.07%+1.61%-4.15%-3.57%-14.43%FREFremont Gold0.00%0.00%0.00%0.00%+15.38%MEDMEDIFAST-1.87%-3.96%-11.69%-16.66%-27.20%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACPAbrdn Income Credit Strategies Fund 0.00N/AN/AN/AFREFremont Gold 0.00N/AN/AN/AMEDMEDIFAST 1.50Reduce$16.5032.50% UpsideCurrent Analyst Ratings BreakdownLatest MED, ACP, POD, MZI, and FRE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025MEDMEDIFASTWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)9/27/2025MEDMEDIFASTWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)(Data available from 10/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACPAbrdn Income Credit Strategies Fund$26.43MN/AN/AN/AN/AN/AFREFremont GoldN/AN/AC$0.08 per share1.84C$0.00 per shareN/AMEDMEDIFAST$602.46M0.23$2.84 per share4.38$19.21 per share0.65Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACPAbrdn Income Credit Strategies FundN/AN/A0.00∞N/AN/AN/AN/AN/AFREFremont Gold-C$6.24M-C$0.11N/A∞N/AN/A-378.07%-104.83%N/AMEDMEDIFAST$2.09M$0.3238.928.14N/A0.76%2.00%1.50%11/3/2025 (Estimated)Latest MED, ACP, POD, MZI, and FRE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/3/2025Q3 2025MEDMEDIFAST-$0.01N/AN/AN/A$84.10 millionN/A8/4/2025Q2 2025MEDMEDIFAST-$0.22$0.04+$0.26$0.22$96.10 million$105.56 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACPAbrdn Income Credit Strategies Fund$0.9516.65%N/AN/AN/AFREFremont GoldN/A12.12%N/AN/AN/AMEDMEDIFASTN/AN/AN/AN/AN/ALatest MED, ACP, POD, MZI, and FRE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date10/9/2025ACPAbrdn Income Credit Strategies Fundmonthly$0.077516.16%10/24/202510/24/202510/31/20259/10/2025ACPAbrdn Income Credit Strategies Fundquarterly$0.328115.97%9/23/20259/23/20259/30/20258/11/2025ACPAbrdn Income Credit Strategies Fundmonthly$0.077515.6%8/22/20258/22/20258/29/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACPAbrdn Income Credit Strategies FundN/AN/AN/AFREFremont GoldN/A0.831.79MEDMEDIFASTN/A4.473.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACPAbrdn Income Credit Strategies FundN/AFREFremont Gold0.69%MEDMEDIFAST95.51%Insider OwnershipCompanyInsider OwnershipACPAbrdn Income Credit Strategies FundN/AFREFremont Gold22.50%MEDMEDIFAST2.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACPAbrdn Income Credit Strategies FundN/AN/AN/ANot OptionableFREFremont GoldN/A58.07 millionN/ANot OptionableMEDMEDIFAST87010.99 million10.67 millionOptionableMED, ACP, POD, MZI, and FRE HeadlinesRecent News About These CompaniesMedifast to Announce Financial Results for the Third Quarter Ended September 30, 2025October 21 at 11:39 AM | finance.yahoo.comMedifast's (MED) Sell (D) Rating Reaffirmed at Weiss RatingsOctober 10, 2025 | marketbeat.comMedifast (NYSE:MED) Stock Crosses Above Two Hundred Day Moving Average - Time to Sell?October 8, 2025 | marketbeat.com3 Reasons to Avoid MED and 1 Stock to Buy InsteadOctober 2, 2025 | msn.comMedifast (NYSE:MED) Stock Price Crosses Above 200 Day Moving Average - What's Next?September 26, 2025 | marketbeat.comWill Medifast's Strategic Endeavors Deliver Growth in 2025?September 19, 2025 | zacks.comWith 78% ownership of the shares, Medifast, Inc. (NYSE:MED) is heavily dominated by institutional ownersSeptember 17, 2025 | finance.yahoo.comEvidence Links 5 & 1 Plan® to Improved Metabolic Health OutcomesSeptember 15, 2025 | businesswire.comMedifast (MED) Up 6.5% Since Last Earnings Report: Can It Continue?September 3, 2025 | zacks.comWhy Medifast (MED) Stock Is Trading Up TodayAugust 23, 2025 | finance.yahoo.comMedifast Bolsters Growth Through Health & Wellness SolutionsAugust 19, 2025 | zacks.com2 Safe-and-Steady Stocks for Long-Term Investors and 1 We Brush OffAugust 15, 2025 | msn.comMED Q2 Deep Dive: Ongoing Coach Decline and GLP-1 Integration Shape OutlookAugust 14, 2025 | uk.finance.yahoo.comDole, B&G Foods, Medifast, USANA, and MGP Ingredients Shares Are Soaring, What You Need To KnowAugust 14, 2025 | msn.com5 Insightful Analyst Questions From Medifast’s Q2 Earnings CallAugust 13, 2025 | finance.yahoo.comMedifast (MED) Stock Trades Up, Here Is WhyAugust 12, 2025 | msn.comMedifast’s Earnings Call: Challenges and OptimismAugust 8, 2025 | theglobeandmail.comMedifast Second Quarter 2025 Earnings: Beats ExpectationsAugust 7, 2025 | finance.yahoo.comMedifast, Inc. (NYSE:MED) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comWhy Medifast (MED) Stock Is Up TodayAugust 5, 2025 | msn.comMedifast's Q2 Earnings Beat Estimates, Lower Revenues Hurt MarginsAugust 5, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesPalantir’s New Healthcare Deal Boosts AI and Data Reach By Chris Markoch | October 15, 20252 Ways to Trade Amazon Ahead of October’s Prime DayBy Sam Quirke | September 24, 2025High-Momentum ETFs to Mine for Gold, Silver, and BitcoinBy Nathan Reiff | September 26, 2025After Gold Blast Soars Past $4,000, BofA Eyes $5,000 in 2026By Leo Miller | October 14, 2025Why the Precious Metal Nobody Talks About Could Be Your Best BetBy Jordan Chussler | October 4, 2025MED, ACP, POD, MZI, and FRE Company DescriptionsAbrdn Income Credit Strategies Fund NYSE:ACP$5.70 +0.04 (+0.62%) Closing price 03:59 PM EasternExtended Trading$5.70 -0.01 (-0.18%) As of 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Abrdn Income Credit Strategies Fund is a closed-ended fixed income fund launched and managed by Aberdeen Asset Managers Limited. It is co-managed by Aberdeen Standard Investments Inc. The fund invests in fixed income markets across the globe. It seeks to invest primarily in loan and debt instruments. Abrdn Income Credit Strategies Fund was formed on October 12, 2010 and is domiciled in the United States.Fremont Gold CVE:FREC$0.15 0.00 (0.00%) As of 11/5/2024Fremont Gold Ltd., an exploration stage company, engages in the acquisition, exploration, and evaluation of mineral properties in the United States and Canada. The company explores for gold and copper deposit. The company was formerly known as Palisades Ventures Inc. and changed its name to Fremont Gold Ltd. in June 2017. Fremont Gold Ltd. was incorporated in 2007 and is headquartered in Vancouver, Canada.MEDIFAST NYSE:MED$12.45 -0.19 (-1.48%) Closing price 03:59 PM EasternExtended Trading$12.48 +0.02 (+0.18%) As of 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Earnings Review: Does the Juice Justify the Squeeze? Boeing Takes Off as FAA Greenlights 737 MAX Production Boost Capital One Just Flashed a Buy Signal—New Highs Could Be Next Why Intuitive Surgical Is a No-Brainer for Long-Term Investors Is Oracle’s AI Rally Over? Wall Street Thinks ORCL Could Hit $400 GM Posts Largest Gain Since the Pandemic: Shares Still Look Cheap 3 Pharmaceutical Growth Stocks to Buy and Hold for 10 Years Why Micron Stock Could Soar 35% on AI Memory Demand Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
